New MRI Technique Shows Promise in Early Parkinson's Detection


Resting-state functional MRI, a new MRI approach, detects early stage Parkinson's disease with 85% accuracy, according to a new study.

Resting-state functional MRI, a new MRI approach, detects early stage Parkinson’s disease with 85% accuracy, according to a new study published online in Neurology on June 11, 2014. The new test focuses on scanning the basal ganglia, the area of the brain associated with Parkinson’s disease.

According to senior researcher Clare Mackay, of Oxford University, the new test’s potential ability for early detection could improve the lives of many patients with Parkinson’s disease because conventional MRI cannot detect early signs of the disease.

“By the time symptoms of Parkinson’s are obvious, a lot of damage has already taken place in the brain,” she said, and to reduce the disease’s impact, new ways must be found to protect the brain before significant damage is done. “We must have good tools to identify people as early as possible in the course of the disease.”

While PET scans have shown promise in early detection of Parkinson’s disease, PET involves a dose of radiation and is very expensive, whereas MRI is not expensive and does not use radiation.

Recent Videos
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
Solutions to Prevent Climate Change-Related Illness, with Janelle Bludhorn, PA-C
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
© 2024 MJH Life Sciences

All rights reserved.